Composition
- Active ingredients
- REPAGLINIDE 1MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- REPAGLINIDE 2MG · TabletANDA077571-003 · Discontinued
- REPAGLINIDE 0.5MG · TabletANDA077571-001 · Tentative approval
- REPAGLINIDE 1MG · TabletANDA077571-002 · Discontinued
- REPAGLINIDE 2MG · TabletANDA091517-003 · Discontinued
- REPAGLINIDE 0.5MG · TabletANDA091517-001 · Discontinued
- REPAGLINIDE 1MG · TabletANDA091517-002 · Discontinued
- REPAGLINIDE 1MG · TabletANDA207209-002 · Prescription
- REPAGLINIDE 2MG · TabletANDA207209-003 · Prescription
- REPAGLINIDE 0.5MG · TabletANDA207209-001 · Prescription
- REPAGLINIDE 2MG · TabletANDA203820-003 · Prescription
- REPAGLINIDE 0.5MG · TabletANDA203820-001 · Prescription
- REPAGLINIDE 1MG · TabletANDA203820-002 · Prescription
- REPAGLINIDE 2MG · TabletANDA090008-003 · Discontinued
- REPAGLINIDE 0.5MG · Tablet
At a glance
- Brand name
- Repaglinide
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Quagen
- Status
- Discontinued
- FDA approval
- 22 Jan 2014
- Application
- ANDA090252-002